Characterizing cardiovascular risk in women with polycystic ovary syndrome: More than the sum of its parts?

Alice Y Chang, Robert A. Wild

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Polycystic ovary syndrome (PCOS), a condition of irregular menses and androgen excess, is the most common endocrinopathy of young women. Insulin resistance is a wellestablished feature among many women with PCOS, even in the nonobese. Therefore, it is not surprising that PCOS is frequently associated with cardiovascular risk factors and the metabolic syndrome. However, it is not known whether PCOS is an independent risk factor for atherosclerosis and cardiovascular (CV) events or whether CV risk is attributable to associated risk factors. We review previous studies on CV risk and disease in women with PCOS, describing the pitfalls and challenges in ascribing CV risk to PCOS. Women with PCOS might be partly reassured that their relative risk approximates that of the metabolic syndrome (RR 1.5) and also strongly counseled at the individual level about the greatest potential threat to their CV health, the development of type 2 diabetes.

Original languageEnglish (US)
Pages (from-to)299-305
Number of pages7
JournalSeminars in Reproductive Medicine
Volume27
Issue number4
DOIs
StatePublished - Jul 2009
Externally publishedYes

Fingerprint

Polycystic Ovary Syndrome
Menstruation
Type 2 Diabetes Mellitus
Androgens
Insulin Resistance
Atherosclerosis
Cardiovascular Diseases
Health

Keywords

  • Androgen excess
  • Cardiovascular disease
  • Insulin resistance
  • Metabolic syndrome
  • Type 2 diabetes

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Obstetrics and Gynecology
  • Physiology (medical)
  • Reproductive Medicine

Cite this

Characterizing cardiovascular risk in women with polycystic ovary syndrome : More than the sum of its parts? / Chang, Alice Y; Wild, Robert A.

In: Seminars in Reproductive Medicine, Vol. 27, No. 4, 07.2009, p. 299-305.

Research output: Contribution to journalReview article

@article{7e722d237c4d4e259c31df14ddbc53d1,
title = "Characterizing cardiovascular risk in women with polycystic ovary syndrome: More than the sum of its parts?",
abstract = "Polycystic ovary syndrome (PCOS), a condition of irregular menses and androgen excess, is the most common endocrinopathy of young women. Insulin resistance is a wellestablished feature among many women with PCOS, even in the nonobese. Therefore, it is not surprising that PCOS is frequently associated with cardiovascular risk factors and the metabolic syndrome. However, it is not known whether PCOS is an independent risk factor for atherosclerosis and cardiovascular (CV) events or whether CV risk is attributable to associated risk factors. We review previous studies on CV risk and disease in women with PCOS, describing the pitfalls and challenges in ascribing CV risk to PCOS. Women with PCOS might be partly reassured that their relative risk approximates that of the metabolic syndrome (RR 1.5) and also strongly counseled at the individual level about the greatest potential threat to their CV health, the development of type 2 diabetes.",
keywords = "Androgen excess, Cardiovascular disease, Insulin resistance, Metabolic syndrome, Type 2 diabetes",
author = "Chang, {Alice Y} and Wild, {Robert A.}",
year = "2009",
month = "7",
doi = "10.1055/s-0029-1225257",
language = "English (US)",
volume = "27",
pages = "299--305",
journal = "Seminars in Reproductive Medicine",
issn = "1526-8004",
publisher = "Thieme Medical Publishers",
number = "4",

}

TY - JOUR

T1 - Characterizing cardiovascular risk in women with polycystic ovary syndrome

T2 - More than the sum of its parts?

AU - Chang, Alice Y

AU - Wild, Robert A.

PY - 2009/7

Y1 - 2009/7

N2 - Polycystic ovary syndrome (PCOS), a condition of irregular menses and androgen excess, is the most common endocrinopathy of young women. Insulin resistance is a wellestablished feature among many women with PCOS, even in the nonobese. Therefore, it is not surprising that PCOS is frequently associated with cardiovascular risk factors and the metabolic syndrome. However, it is not known whether PCOS is an independent risk factor for atherosclerosis and cardiovascular (CV) events or whether CV risk is attributable to associated risk factors. We review previous studies on CV risk and disease in women with PCOS, describing the pitfalls and challenges in ascribing CV risk to PCOS. Women with PCOS might be partly reassured that their relative risk approximates that of the metabolic syndrome (RR 1.5) and also strongly counseled at the individual level about the greatest potential threat to their CV health, the development of type 2 diabetes.

AB - Polycystic ovary syndrome (PCOS), a condition of irregular menses and androgen excess, is the most common endocrinopathy of young women. Insulin resistance is a wellestablished feature among many women with PCOS, even in the nonobese. Therefore, it is not surprising that PCOS is frequently associated with cardiovascular risk factors and the metabolic syndrome. However, it is not known whether PCOS is an independent risk factor for atherosclerosis and cardiovascular (CV) events or whether CV risk is attributable to associated risk factors. We review previous studies on CV risk and disease in women with PCOS, describing the pitfalls and challenges in ascribing CV risk to PCOS. Women with PCOS might be partly reassured that their relative risk approximates that of the metabolic syndrome (RR 1.5) and also strongly counseled at the individual level about the greatest potential threat to their CV health, the development of type 2 diabetes.

KW - Androgen excess

KW - Cardiovascular disease

KW - Insulin resistance

KW - Metabolic syndrome

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=67650538573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650538573&partnerID=8YFLogxK

U2 - 10.1055/s-0029-1225257

DO - 10.1055/s-0029-1225257

M3 - Review article

C2 - 19530063

AN - SCOPUS:67650538573

VL - 27

SP - 299

EP - 305

JO - Seminars in Reproductive Medicine

JF - Seminars in Reproductive Medicine

SN - 1526-8004

IS - 4

ER -